RSN Letters to Regulatory Agencies

Click title text below to read each PDF:

January 5, 2024: Contract Year 2025 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly; Health Information Technology Standards and Implementation Specifications” Proposed Rule (MA Proposed Rule)

December 13, 2023: CMS-3742-P: ESRD Dialysis Patient Life Goals Survey (PaLS)

September 12, 2023: Improving the OPTN System for people in needs of a life-saving organ

August 8, 2023: Re: CMS-1782-P, End-Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End-Stage Renal Disease Quality Incentive Program, and End-Stage Renal Disease Treatment Choices Model

June 23, 2023: CMS-3742-P: ESRD Dialysis Patient Life Goals Survey (PaLS)

May 3, 2023: Molecular Testing for Solid Organ Allograft Rejection (A58019) 

May 1, 2023: Representative Bucshon and Representative Kelly; Securing the U.S. Organ Procurement and Transplantation Network Act (H.R. 2544) Stakeholder Letter

April 18, 2023: The Honorable Xavier Becerra Secretary, U.S. Department of Health and Human Services, regarding the Organ Procurement and Transplant Network (OPTN) Modernization Initiative

August 30, 2022 CMS-1770-P: “CY 2023 Payment Policies under the Physician Fee Schedule and Other Changes to Part B Payment Policies; Medicare Shared Savings Program Requirements; Medicare and Medicaid Provider Enrollment Policies

August 23, 2022 CMS–4203–NC Medicare Program; Request for Information on Medicare Advantage

August 18, 2022 CMS–1768–P: End-Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End-Stage Renal Disease Quality Incentive Program, and End-Stage Renal Disease Treatment Choices Model 

August 17, 2022 Living Donor Protection Act of 2021(H.R.1255) Stakeholder Letter

January 31, 2022: Re: Request for Information; Health and Safety Requirements for Transplant Programs, Organ Procurement Organizations, and End-Stage Renal Disease Facilities

December 6, 2021: Patient Access to and Adequate Reimbursement for Innovative ESRD Treatment

August 26, 2021: 2 RSN’s Response Letter to CMS Regarding Changes to the End-Stage Renal Disease (ESRD) Prospective Payment System and Quality Initiative Program (QIP)

August 17, 2021: RSN’s Response Letter to FDA Regarding New Drug Application

April 6, 2020: RSN Responds to HHS Rule that will allow people who have ESRD to join Managed Care Programs in 2021

February 21, 2020: RSN Founder and President Lori Hartwell sends letter to Secretary Azar and Administrator Verma regarding CMS–3380–P: Medicare and Medicaid Programs; Organ Procurement Organizations Conditions for Coverage: Revisions to the Outcome Measure Requirements for Organ Procurement Organization

September 16, 2019: RSN Founder and President Lori Hartwell sends letter to Secretary Azar and Administrator Verma regarding the Medicare Program: Specialty Care Models to Improve Quality of Care and Reduce Expenditures directed from the Executive Order on Advancing Kidney Health

 

 

 

 

Web Id 8016